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NF-κB inhibition in keratinocytes causes RIPK1-mediated
necroptosis and skin inflammation
Snehlata Kumari1,* , Trieu-My Van1,*, Daniela Preukschat1, Hannah Schuenke1, Marijana Basic2, André Bleich2, Ulf Klein3,
Manolis Pasparakis1
Tumor necrosis factor receptor 1 (TNFR1) activatesNF-κB–dependent
pro-inflammatory gene expression, but also induces cell
death by triggering apoptosis and necroptosis. Inhibition of
inhibitor of NF-κB kinase (IKK)/NF-κB signaling in keratino-
cytes paradoxically unleashed spontaneous TNFR1-mediated
skin inflammation in mice, but the underlying mechanisms
remain poorly understood. Here, we show that TNFR1 causes
skin inflammation in mice with epidermis-specific knockout of
IKK2 by inducing receptor interacting protein kinase 1 (RIPK1)–
dependent necroptosis, and to a lesser extent also apoptosis,
of keratinocytes. Combined epidermis-specific ablation of the
NF-κB subunits RelA and c-Rel also caused skin inflammation
by inducing TNFR1-mediated keratinocyte necroptosis. Con-
trary to the currently established model that inhibition of NF-
κB–dependent gene transcription causes RIPK1-independent
cell death, keratinocyte necroptosis, and skin inflammation in
mice with epidermis-specific RelA and c-Rel deficiency also
depended on RIPK1 kinase activity. These results advance our
understanding of the mechanisms regulating TNFR1-induced
cell death and identify RIPK1-mediated necroptosis as a potent
driver of skin inflammation.
DOI 10.26508/lsa.202000956 | Received 13 November 2020 | Revised 1 April
2021 | Accepted 1 April 2021 | Published online 15 April 2021
Introduction
The skin constitutes an essential structural and immunological
barrier protecting the organism from microbial challenges. The
maintenance of a healthy skin homeostasis requires a proper
balance between cell proliferation, differentiation, death, and a
tightly regulated cross talk between epithelial and immune cells.
Deregulation of this balance results in chronic inflammatory skin
diseases, such as psoriasis. Whereas early studies of the mecha-
nisms driving the pathogenesis of inflammatory skin diseases
focused on the role of immune cells, recent studies in genetic
mouse models have highlighted the importance of keratinocyte-
intrinsic mechanisms in regulating skin immune homeostasis and
inflammation (Pasparakis et al, 2014). TNF is a potent inducer of
inflammation that has emerged as an important therapeutic target
in chronic inflammatory diseases, including rheumatoid arthritis,
inflammatory bowel disease, and psoriasis (Chaudhari et al, 2001;
Peyrin-Biroulet, 2010; Monaco et al, 2015). However, despite the
proven clinical efficacy of anti-TNF therapy, the molecular mech-
anisms by which TNF triggers inflammation in these patients remain
poorly understood.
TNF binding to tumor necrosis factor receptor 1 (TNFR1) initiates
the formation of a receptor-proximal signaling complex (termed
complex I) composed of receptor interacting protein kinase 1
(RIPK1), TNFR1-associated death domain protein (TRADD), TNFR-
associated factor 2 (TRAF2), and the E3 ubiquitin ligases cellular
inhibitors of apoptosis (cIAP) 1 and 2. Ubiquitination of RIPK1 with
K63-linked ubiquitin chains by cIAPs promotes the recruitment of
the linear ubiquitin assembly complex (LUBAC), consisting of
SHANK-associated RH domain-interacting protein (Sharpin), Heme-
oxidized iron-regulatory protein 2 ubiquitin ligase-1 (HOIL-1), and
HOIL-1–interacting protein (HOIP), as well as of the transforming
growth factor-β-activated kinase 1 (TAK1)/TAK1-binding protein
(TAB)1/2 complex. LUBAC ubiquitinates RIPK1 but also other pro-
teins within the complex with linear Ub chains, which allows the
recruitment of the IκB kinase (IKK) complex, consisting of the
regulatory subunit NF-κB essential modulator (NEMO) and the
catalytic subunits IKK2/IKKβ and IKK1/IKKα (Wertz et al, 2015; Ting &
Bertrand, 2016; Varfolomeev & Vucic, 2018). IKK is activated within
this complex and mediates phosphorylation and subsequent
degradation of inhibitor of NF-κB (IκB) proteins resulting in the
activation of the transcription factor NF-κB, which is composed of
five subunits: RelA, c-Rel, RelB, p50, and p52 that form hetero- and
homo-dimers (Oeckinghaus & Ghosh, 2009). NF-κB activation in-
duces the expression of genes promoting immune responses and
inflammation but also of genes promoting cell survival and
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preventing cell death. Indeed, inhibition of NF-κB or destabilization
of complex I sensitize cells to TNF-induced death by promoting
the formation of death-inducing signaling complexes (Varfolomeev
& Vucic, 2018). TNFR1 has been shown to induce caspase-8–
dependent apoptosis via two distinct cell death-inducing signaling
complexes that depend on either TRADD (complex IIa) or RIPK1
(complex IIb) (Micheau & Tschopp, 2003; Wang et al, 2008;
Varfolomeev & Vucic, 2018). When caspase-8 is inhibited, TNFR1
induces necroptosis, an inflammatory type of necrotic cell death,
via the RIPK1-dependent activation of RIPK3, which subsequently
phosphorylates and activates the pseudokinase mixed lineage
kinase like (MLKL) that executes necroptosis by damaging the
plasma membrane (Sun et al, 2012; Zhao et al, 2012; Murphy et al,
2013; Cai et al, 2014; Chen et al, 2014; Dondelinger et al, 2014;
Pasparakis & Vandenabeele, 2015; Grootjans et al, 2017).
Two distinct checkpoints have been proposed to regulate TNF-
induced cell death by acting on distinct cell death-inducing protein
complexes. Checkpoint 1 acts at the level of RIPK1, by preventing the
activation of its kinase activity via direct phosphorylation by IKK1/2 as
well as TBK1, whereas checkpoint 2 prevents TRADD-dependent apo-
ptosis via theNF-κB–dependent expressionof pro-survival genes (Justus
& Ting, 2015; Ting & Bertrand, 2016; Lafont et al, 2018). According to the
currently prevalent model, inhibition of NF-κB–dependent gene tran-
scription triggers TRADD-FADD-caspase-8–dependent apoptosis via
complex IIa, whereas inhibition of checkpoint 1 by blocking IKKs or TBK1
or destabilization of complex I by inhibition of cIAPs or LUBAC, triggers
RIPK1-FADD-caspase-8–mediated apoptosis via complex IIb (Justus &
Ting, 2015; Ting & Bertrand, 2016). Under conditions of caspase-8 inhi-
bition, complex IIb engages RIPK3 to form the necrosome resulting
in MLKL-dependent necroptosis (Pasparakis & Vandenabeele, 2015;
Grootjans et al, 2017). Consistent with this model, inhibition of RIPK1
kinase activity was shown to prevent skin inflammation in mice lacking
sharpin (Sharpincpdm/cpdm), by inhibiting TNFR1-mediated FADD-cas-
pase-8–dependent keratinocyte apoptosis (Berger et al, 2014; Kumari
et al, 2014; Laurien et al, 2020; Webster et al, 2020).
Mice with epidermis-specific deletion of IKK2 (Ikk2fl/fl K14-Cretg/wt,
hereafter referred to as IKK2E-KO) develop severe psoriasis-like
skin inflammation characterized by epidermal hyperplasia, al-
tered keratinocyte differentiation, up-regulation of cytokines and
chemokines, and accumulation of immune cells in the skin
(Pasparakis et al, 2002; Stratis et al, 2006a, 2006b; Kumari et al,
2013). Keratinocyte-specific ablation of TNFR1 completely pre-
vented inflammatory skin lesion development in IKK2E-KO mice
(Kumari et al, 2013). Furthermore, mice with keratinocyte-specific
knockout of both RelA and c-Rel (Relafl/fl c-Relfl/fl K14-Cretg/wt,
hereafter referred to as RelAE-KO c-RelE-KO mice) also developed
inflammatory skin lesions resembling the phenotype of IKK2E-KOmice
(Grinberg-Bleyer et al, 2015). These results showed that, paradoxically
considering the established pro-inflammatory role of NF-κB, inhi-
bition of IKK/NF-κB signaling in the epidermis triggers psoriasis-like
skin inflammation in mice. The mechanisms by which IKK/NF-κB
signaling in keratinocytes prevents inflammation have remained
poorly understood. Here, we provide evidence that inhibition of
IKK or NF-κB signaling induced skin inflammation by triggering
keratinocyte death primarily by necroptosis. Surprisingly, and con-
trary to the currently accepted model of two distinct checkpoints
regulating TNF-induced cell death, we found that RIPK1 kinase
activity inhibition prevented skin inflammation in both IKK2E-KO and
RelAE-KO c-RelE-KO mice. These in vivo findings identify keratinocyte
necroptosis as a key driver of TNF-mediated skin inflammation and
provide a paradigm shift in our understanding of the mechanisms
by which IKK and NF-κB signaling regulate TNF-induced cell death.
Results
TNF induces death in IKK2-deficient keratinocytes
To address whether IKK2 deficiency induces death of epidermal kera-
tinocytes, we stained skin sections from IKK2E-KO and littermate control
mice at postnatal days 1 (P1), P4 andP8with antibodies against activated
cleaved caspase-3 (CC3) and with terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL). The skin of IKK2E-KO mice showed a
progressive increase in the number of CC3 and TUNEL-positive cells in
the epidermis (Fig 1A), suggesting that IKK2 deficiency triggers death of
keratinocytes. To assess whether death of IKK2-deficient keratinocytes is
triggered by TNF, we first isolated primary keratinocytes from newborn
control and IKK2E-KO pups and stimulated them with TNF. Indeed, IKK2-
deficient keratinocytes showed enhanced TNF-induced cell death
comparedwith control keratinocytes (Fig 1B). To assess the role of TNFR1
in vivoweexamined skin sections frommice lackingboth IKK2 andTNFR1
in the epidermis (IKK2E-KO TNFR1E-KOmice) and found that TNFR1 ablation
prevented keratinocyte death (Fig 1C). Therefore, TNFR1 induces kera-
tinocyte death in IKK2E-KO mice. To gain insight into the potential
mechanisms by which IKK2 prevents keratinocyte death, we measured
the expression of the pro-survival genes Cflar, Birc2, Birc3, and Birc5 in
the epidermis of IKK2E-KO mice. Cflar and Birc2 mRNA expression was
reduced in the epidermis of IKK2E-KOmice comparedwith their littermate
controls at P4 (Fig 1D), which could contribute to the sensitizationof IKK2-
deficient keratinocytes to TNF-induced cell death in vivo. In addition, we
detectedup-regulationof cytokines and chemokines, including Il-1b, Il-6,
Il-24, Ccl3, and Ccl4, in the epidermis of IKK2E-KO mice at P4, indicating
ongoing inflammation alongside the death of keratinocytes in IKK2E-KO
mice (Fig 1E).
Microscopically, skin lesion development in IKK2E-KO mice starts
between P3-P4, suggesting that colonization of the skin with
commensal bacteria could provide the trigger. To address whether
the microbiota could potentially contribute to skin lesion devel-
opment in IKK2E-KO mice, we analyzed IKK2E-KO mice raised under
germ-free (GF) conditions. These experiments showed that GF
IKK2E-KO mice developed similar inflammatory skin lesions as seen
in IKK2E-KO mice raised under specific pathogen-free conditions,
characterized with increased epidermal thickness, elevated ex-
pression of keratin 6 (K6) and K14, reduced expression of K10, and
increased number of dying keratinocytes (Fig S1A and B). Therefore,
microbiota colonization is not required for the postnatal onset of
skin inflammation in IKK2E-KO mice.
Inhibition of both apoptosis and necroptosis prevents skin
inflammation in IKK2E-KO mice
TNFR1 induces cell death by activating both FADD-caspase-
8–dependent apoptosis and RIPK3-MLKL–dependent necroptosis.
To assess whether TNFR1-mediated FADD-caspase-8–dependent
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Figure 1. IKK2 deficiency induces TNF-mediated death of primary keratinocytes.
(A) Skin sections fromP1-P8pups stainedwith TUNEL andCC3. Representative images are shown (control and IKK2E-KO n = 3). Scale bars, 50μm. (B)Primary keratinocytes fromControl or
IKK2E-KO (n = 6) mice were treated with TNF (20 ng/ml) for 18 h. Cell viability was determined by WST-1 assay. Graphs show mean ± SEM from pooled data from three independent
experiments.Multiple comparisonsof groupswereevaluatedbyKruskal–Wallis one-wayANOVAswithpost-Dunncorrections. (C)Skin sections fromP7-P8pups stainedwith TUNEL andCC3.
Representative imagesare shown (control, IKK2E-KOand IKK2E-KO TNFR1E-KOn= 3). Scalebars, 50μm. (D, E)qRT-PCRanalysisof themRNAexpressionof the indicatedgenes inRNA isolated
from the P4 epidermis of the mice with the indicated genotypes. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.005.
Source data are available for this figure.
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apoptosis contributes to skin inflammation we crossed the IKK2E-KO
mice with Faddfl/fl animals to generate mice lacking both IKK2 and
FADD in keratinocytes. These IKK2E-KO FADDE-KO mice developed
severe inflammatory skin lesions at P6-P7 (Fig S2A), showing that
FADD deficiency could not prevent skin inflammation in IKK2E-KO
mice. Consistently, Z-VAD could not prevent the TNF-induced death
in IKK2-deficient primary keratinocytes (Fig S2B). Because
epidermis-specific FADD deficiency itself triggers severe skin in-
flammation by sensitizing keratinocytes to RIPK3-mediated nec-
roptosis (Bonnet et al, 2011), we could not conclude from these
results whether FADD deficiency could not prevent skin inflam-
mation in IKK2E-KO mice or if the phenotype of the IKK2E-KO FADDE-KO
mice was induced by FADD ablation alone in the epidermis.
Therefore, to address the role of keratinocyte death in skin in-
flammation in IKK2E-KO mice, we generated Ikk2fl/fl K14-Cretg/wt
Faddfl/fl Ripk3−/− mice (hereafter referred to as IKK2E-KO FADDE-KO
Ripk3−/−), which lack IKK2 and FADD specifically in keratinocytes and
RIPK3 in all cells. FADD deficiency prevents caspase-8–mediated
apoptosis and RIPK3 deficiency prevents necroptosis; therefore, if
death of keratinocytes would be important for the pathogenesis of
the skin lesions, we would expect that IKK2E-KO FADDE-KO Ripk3−/−
should not develop the pathology. Indeed, the triple mutant IKK2E-KO
FADDE-KO Ripk3−/− mice were indistinguishable from their litter-
mate controls and did not show skin lesions at the age of 7–8 d
after birth (Fig 2A). Histological analysis of skin sections confirmed
that IKK2E-KO FADDE-KO Ripk3−/− mice did not show death of ker-
atinocytes and did not develop epidermal hyperplasia and in-
flammation at P7-P8 (Fig 2A and B). The IKK2E-KO FADDE-KO Ripk3−/−
mice remained healthy without showing any signs of skin in-
flammation at least until the age of 1 yr (Fig 2A and Table S1).
Furthermore, the epidermis of IKK2E-KO FADDE-KO Ripk3−/− mice at
P4 did not show up-regulation of cytokine and chemokine ex-
pression in contrast to the epidermis of IKK2E-KO mice (Fig 2C).
Therefore, combined deficiency in FADD and RIPK3 completely
prevented the development of skin lesions in IKK2E-KO mice,
demonstrating that death of keratinocytes by apoptosis and/or
necroptosis caused skin inflammation in these mice.
RIPK3-MLKL–dependent keratinocyte necroptosis is the major
driver of skin inflammation in IKK2E-KO mice
Having established cell death as an essential trigger for the development
of skin lesions in IKK2E-KO mice, we wondered whether the pathology is
triggered by keratinocyte apoptosis or necroptosis. Necroptosis is gen-
erally considered an inflammatory type of cell death as opposed to
apoptosis that is not considered a strong inducer of inflammation.
However, previous studies showed that keratinocyte apoptosis drives
skin inflammation in Sharpincpdm/cpdm, whereas necroptosis plays a
minor role in this model (Kumari et al, 2014; Rickard et al, 2014;
Webster et al, 2020), suggesting that interfering with complex I
function in keratinocytes primarily drives keratinocyte apoptosis.
To assess the specific function of necroptosis, we crossed IKK2E-KO
mice with RIPK3-deficient animals. Macroscopic examination
revealed a strong amelioration of the skin pathology in IKK2E-KO
Ripk3−/− mice, which showed only a few small patches of mildly
affected skin at P7-P8 as opposed to the severe skin lesions ob-
served in IKK2E-KO mice at this age (Fig 3A). Moreover, histological
analysis of skin sections revealed only small patches showing
mildly increased epidermal thickness and inflammation in IKK2E-KO
Ripk3−/− mice compared with the severely affected skin of IKK2E-KO
mice (Fig 3B and C). Immunofluorescence staining of skin sections
from IKK2E-KO Ripk3−/−mice at P7-P8 showed onlymild alterations of
epidermal differentiation markers and presence of a few CC3 and
TUNEL positive cells in the epidermis, accompanied with mild
accumulation of immune cells in the dermis (Fig 3B and C). Fur-
thermore, RIPK3 deficiency strongly prevented the expression of
cytokines and chemokines in the epidermis of IKK2E-KO mice at P4,
consistent with the histological assessment (Fig 3D). However,
IKK2E-KO Ripk3−/−mice started to develop progressive skin lesions at
the age of about 2–3 mo, which however remained mild compared
with the severe skin inflammation of IKK2E-KO mice (Fig 3A and Table
S2). These findings suggested that RIPK3-dependent necroptosis
plays an important role for skin lesion development in IKK2E-KO
mice. However, RIPK3 was reported to regulate inflammation in a
cell death–independent manner by acting in myeloid cells
(Moriwaki et al, 2014, 2017; Moriwaki & Chan, 2017). We therefore
addressed the keratinocyte-intrinsic function of RIPK3 by gener-
ating Ikk2fl/fl Ripk3fl/fl K14-Cretg/wt mice (IKK2E-KO RIPK3E-KO). Epi-
dermal keratinocyte-specific RIPK3 knockout fully recapitulated the
effect of systemic RIPK3 deficiency, with IKK2E-KO RIPK3E-KO showing
strongly ameliorated skin inflammation at P7-P8 but developing
progressive mild skin lesions at the age of about 2–5 mo (Fig 3A and
B and Table S3). Because RIPK3 has been reported to also mediate
necroptosis-independent functions (Moriwaki & Chan, 2017), we
further assessed whether RIPK3 deficiency prevented the death of
IKK2-deficient keratinocytes. Indeed, RIPK3 deficiency partially
inhibited the TNF-induced death of keratinocytes lacking IKK2 (Fig
S2C). In addition, the primary keratinocytes from IKK2E-KO FADDE-KO
Ripk3−/− mice were fully protected from TNF-induced death (Fig
S2C), showing that IKK2 deficiency sensitizes keratinocytes to both
necroptosis and apoptosis. Taken together, these results showed
that RIPK3 acts in a keratinocyte-intrinsic manner to drive skin
inflammation in IKK2E-KO mice, suggesting that keratinocyte nec-
roptosis drives the pathology.
To unequivocally address the role of necroptosis in vivo, we
crossed the IKK2E-KO mice with mice lacking MLKL, the terminal
executioner of necroptosis (Sun et al, 2012). IKK2E-KO Mlkl−/− mice
were strongly protected from skin inflammation at P7-P8, similarly
to IKK2E-KO Ripk3−/− and IKK2E-KO RIPK3E-KO mice (Fig 4A). Histological
and immunofluorescence analysis of skin sections revealed small
patches with slightly increased epidermal thickness, mild alter-
ations in epidermal differentiation markers, as well as the presence
of a few dying cells in the epidermis of IKK2E-KO Mlkl−/− mice (Fig 4A
and B). MLKL deficiency also strongly reduced the expression of
cytokines and chemokines expression in the epidermis of IKK2E-KO
mice (Fig 4C). Moreover, IKK2E-KO Mlkl−/− mice started to develop
progressive skin lesions at the age of 2–3 mo similarly to the
IKK2E-KO Ripk3−/− and IKK2E-KO RIPK3E-KO mice (Fig 4A and Table S4).
Collectively, these results revealed that RIPK3-MLKL–dependent
necroptosis of keratinocytes constitutes the major trigger of skin
inflammation in IKK2E-KOmice particularly early after birth; however,
necroptosis-independent mechanisms drive skin lesion develop-
ment later in life. Our findings that IKK2E-KO FADDE-KO Ripk3−/− mice
were fully protected from skin lesion development demonstrate
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Figure 2. Inhibition of RIPK3 and epidermal FADD prevents skin inflammation in IKK2E-KO mice.
(A) Representative macroscopic mouse pictures and skin sections frommice with the indicated age and genotype stained with H&E or immunostained with the indicated antibodies.
Representative images are shown (IKK2E-KO n = 6 for H&E, and n ≥ 5 for immunostainings; IKK2E-KO FADDE-KO Ripk3−/− n = 9 [P7-P8] & n = 22 [P134-P385] for H&E, and n ≥ 3 for
immunostainings). Scale bars, 50μm. (B)Microscopic quantification of epidermal thickness (Epi. th.) and inflamed skin area (Infl. area) aswell as quantification of TUNEL&CC3positive cells
on the skin sections from 7- to 8-d-oldmicewith the indicated genotypes. (C)qRT-PCR analysis of themRNAexpression of the indicated cytokines and chemokines in RNA isolated from
the epidermis of 4-d-old mice with the indicated genotypes. Each dot represents individual mice.
Source data are available for this figure.
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Figure 3. RIPK3-mediated keratinocyte death drives skin inflammation in IKK2E-KO mice.
(A, B)Representativemacroscopicmouse pictures and skin sections frommicewith the indicated age and genotype stainedwith H&E or immunostainedwith the indicated antibodies.
Representative images are shown (IKK2E-KO n = 6 for H&E, and n ≥ 5 for immunostainings; IKK2E-KO Ripk3−/− n = 8 [P7-P8] & n = 16 [P42-P98] for H&E, n ≥ 3 for immunostainings;
IKK2E-KO RIPK3E-KO n = 7 [P7-P8]& n = 12 [P58-P191] for H&E, and n ≥ 3 for immunostainings; IKK2E-KOMlkl−/−n = 9 [P7-P8]& n = 7 [P66-P103] for H&E, and n ≥ 3 for immunostainings).
Scale bars, 50 μm. (C)Microscopic quantification of epidermal thickness (Epi. th.) and inflamed skin area (Infl. area) as well as quantification of TUNEL and CC3-positive cells
on the skin sections from 7- to 8-d-old mice with the indicated genotypes. (D) qRT-PCR analysis of the mRNA expression of the indicated cytokines and chemokines in RNA
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that FADD-caspase-8–dependent apoptosis also contributes to skin
lesion development when necroptosis is blocked.
RIPK1 kinase activity drives keratinocyte death and skin
inflammation in IKK2E-KO mice
RIPK1 kinase activity regulates both apoptosis and necroptosis down-
stream of TNFR1 signaling (Christofferson et al, 2014; Pasparakis &
Vandenabeele, 2015). Therefore, to address the role of RIPK1 kinase
activity in the pathogenesis of skin lesions in IKK2E-KO mice, we
crossed them with knock-in mice expressing kinase inactive RIPK1
(Ripk1D138N/D138N) (Polykratis et al, 2014). IKK2E-KORipk1 D138N/D138Nmice
did not show any macroscopically visible skin lesions at P7-P8, when all
IKK2E-KO mice displayed severely inflamed skin (Fig 5A). In addition,
histological and immunofluorescence examination of skin sections from
IKK2E-KO Ripk1D138N/D138N mice showed normal epidermal thickness, dif-
ferentiationmarker expressionandF4/80+ immunecell infiltration (Fig 5A
and B). Furthermore, lack of RIPK1 kinase activity prevented the up-
regulation of cytokine and chemokine expression, including IL-1b, Il-24,
Ccl3, and Ccl4, in the epidermis of IKK2E-KO mice at P4 (Fig 5C). In addition,
TUNEL and CC3-positive cells were not detected in the epidermis of
IKK2E-KO Ripk1D138N/D138N mice, whereas lack of RIPK1 kinase activity also
prevented the TNF-induced death of primary IKK2-deficient keratino-
cytes (Figs 5A and B and S2C). Most of the IKK2E-KO Ripk1D138N/D138N mice
reached adulthood without showing signs of skin inflammation, with
only a few of these mice showing mild skin lesions between 5 and 9 mo
of age (Fig 5A and Table S5). Taken together, these results showed that
RIPK1 kinase activity drives keratinocyte necroptosis and apoptosis and
triggers the development of inflammatory skin lesions in IKK2E-KO mice.
NF-κB inhibition causes skin inflammation by inducing
RIPK1-dependent keratinocyte necroptosis
IKK2 is themain catalytic subunit of the IKK complex that is responsible
for activation of canonical NF-κBby phosphorylating and triggering the
degradation of IκBα, resulting in the nuclear translocation of NF-κB
dimers and the transcriptional induction of NF-κB target genes
(Oeckinghaus & Ghosh, 2009). NF-κB–dependent expression of pro-
survival genes has been shown to prevent TNF-induced apoptosis (Beg
& Baltimore, 1996; Stehlik et al, 1998; Wang et al, 1998; Barkett &
Gilmore, 1999; Chen et al, 2000; Karin & Lin, 2002). However, IKK2
also inhibits RIPK1-mediated apoptosis and necroptosis by directly
phosphorylating RIPK1 to suppress its kinase activity (Dondelinger et al,
2015, 2019). Therefore, we wanted to address whether epithelial-
specific IKK2 ablation causes keratinocyte death and skin inflam-
mation directly by phosphorylating RIPK1 or by inducing NF-κB–
dependent pro-survival gene transcription. To this end, we
generated mice with epidermis-specific knockout of RelA and c-Rel,
the two NF-κB subunits that are responsible for the transcriptional
activation of canonical NF-κB target genes, by crossing Relafl/fl c-Relfl/fl
mice with K14-Cre. These RelAE-KO c-RelE-KO mice were indistinguish-
able from their Relafl/fl c-Relfl/fl littermate controls at birth but started
to develop inflammatory skin lesions at around P4, which progressed
to widespread inflammatory skin pathology by P8-P11. The inflam-
matory skin lesions of RelAE-KO c-RelE-KO mice resembled the phe-
notype of IKK2E-KO mice, although the pathology was generally milder
(Fig 6A). Histological and immunofluorescence analysis of skin sections
revealed epidermal hyperplasia, altered expression of epidermal dif-
ferentiation markers and accumulation of immune cells in the skin of
RelAE-KO c-RelE-KO mice at P8-P11 (Fig 6B and C). Moreover, increased
numbers of dying keratinocytes were detected by TUNEL and CC3
staining in the epidermis of RelAE-KO c-RelE-KOmice (Fig 6B). Consistently,
primary keratinocytes from RelAE-KO c-RelE-KO mice showed increased
death in response to TNF stimulation (Fig 6D). Therefore, combined
ablation of RelA and c-Rel caused keratinocyte death and skin in-
flammation recapitulating the skin pathology caused by epithelial IKK2
deficiency.
We then wondered if keratinocyte necroptosis drives skin in-
flammation in RelAE-KO c-RelE-KO mice similarly to IKK2E-KO mice.
Indeed, MLKL deficiency strongly protected RelAE-KO c-RelE-KO mice
from the development of inflammatory skin lesions. RelAE-KO c-RelE-KO
Mlkl−/− mice did not show macroscopically visible skin lesions at
P8-P12, in contrast to the severe skin lesions developing in RelAE-KO
c-RelE-KO mice at this age (Fig 6A). Immunohistological analysis of
skin sections fromRelAE-KO c-RelE-KOMlkl−/−mice at P8-P12 revealed a
normal skin without signs of hyperplasia and inflammation, con-
firming that MLKL deficiency prevented skin lesion development in
RelAE-KO c-RelE-KO mice (Fig 6A–C). RelAE-KO c-RelE-KO Mlkl−/− mice
reached adulthood without showing macroscopically visible skin pa-
thology but started to develop skin lesions at about 3–4mo of age, which
remained very mild compared with the skin lesions of RelAE-KO c-RelE-KO
mice (Fig 6A and B and Table S6). Therefore, MLKL deficiency strongly
prevented skin lesion development in RelAE-KO c-RelE-KO mice demon-
strating that necroptosis is a major driver of the pathology. Of note, the
effect ofMLKLdeficiency inpreventing skin lesiondevelopmentwasmuch
stronger in RelAE-KO c-RelE-KO mice compared with the IKK2E-KO mice.
Previous studies primarily using in vitro cell culture approaches
showed that NF-κB or IKK inhibition sensitized cells to TNF-induced
death via different mechanisms: NF-κB inhibition caused RIPK1-
independent death, whereas inhibition of IKK activity caused RIPK1-
dependent cell death (Dondelinger et al, 2015, 2019; Justus & Ting,
2015). Based on these studies, we expected that inhibition of RIPK1
kinase activity should not prevent keratinocyte death and skin
inflammation caused by NF-κB inhibition in RelAE-KO c-RelE-KO mice.
To assess the role of RIPK1 kinase activity, we generated and an-
alyzed RelAE-KO c-RelE-KO Ripk1D138N/D138N mice. Contrary to expec-
tations, inhibition of RIPK1 kinase activity strongly prevented the
development of inflammatory skin lesions in RelAE-KO c-RelE-KO
mice. RelAE-KO c-RelE-KO Ripk1D138N/D138N mice did not show any
macroscopically or histologically detected signs of skin inflam-
mation at P8-P12 (Fig 6A–C). RelAE-KO c-RelE-KO Ripk1D138N/D138N mice
remained healthy during the first months of life; however, some of
these animals developed mild to moderate skin lesions between
the age of 6–9 mo (Fig 6A and B and Table S7). To address whether
isolated from the epidermis of 4-d-old mice with the indicated genotypes (data for Ikk2fl/fl and IKK2E-KO mice are same as in Fig 1 and are shown for comparison). Each dot
represents individual mice. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.005. Arrows indicate skin lesions.
Source data are available for this figure.
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Figure 4. Mixed lineage kinase like-dependent necroptosis drives skin inflammation in IKK2E-KO mice.
(A) Representative macroscopic mouse pictures and skin sections from mice with the indicated age and genotype stained with H&E or immunostained with the indicated antibodies.
Representative imagesareshown(IKK2E-KOn= 6 forH&E,andn≥ 5 for immunostainings; IKK2E-KOMlkl−/−n= 9 [P7-P8]&n= 7 [P66-P103] forH&E,andn≥ 3 for immunostainings). Scalebars, 50μm.
(B)Microscopic quantification of epidermal thickness (Epi. th.) and inflamed skin area (Infl. area) aswell as quantification of TUNEL&CC3positive cells on the skin sections from 7- to 8-d-oldmice
with the indicated genotypes. (C) qRT-PCR analysis of themRNA expression of the indicated cytokines and chemokines in RNA isolated from the epidermis of 4-d-oldmice with the indicated
genotypes (data for Ikk2fl/fland IKK2E-KOmicearesameas inFig 1andareshown forcomparison). Eachdot represents individualmice. *P≤ 0.05; **P≤ 0.01; ***P≤ 0.005. Arrows indicateskin lesions.
Source data are available for this figure.
NF-kB prevents keratinocyte necroptosis and skin inflammation Kumari et al. https://doi.org/10.26508/lsa.202000956 vol 4 | no 6 | e202000956 8 of 14
Figure 5. Kinase activity of RIPK1 triggers skin inflammation in IKK2E-KO mice.
(A) Representative macroscopic mouse pictures and skin sections from mice with the indicated age and genotype stained with H&E or immunostained with the
indicated antibodies. Representative images are shown (IKK2E-KO n = 6 for H&E and n ≥ 5 for immunostainings; IKK2E-KO Ripk1D138N/D138N n = 12 [P7-P8] & n = 20 [P136-P410]
for H&E and n ≥ 3 for immunostainings). Scale bars, 50 μm. (B) Microscopic quantification of epidermal thickness (Epi. th.) and inflamed skin area (Infl. area) as well as
quantification of TUNEL & CC3 positive cells on the skin sections from 7- to 8-d-old mice with the indicated genotypes. (C) qRT-PCR analysis of the mRNA expression of
the indicated cytokines and chemokines in RNA isolated from the epidermis of 4-d-old mice with the indicated genotypes (data for Ikk2fl/fl and IKK2E-KO mice are same as
in Fig 1 and are shown for comparison). Each dot represents individual mice. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.005. Arrows indicate skin lesions.
Source data are available for this figure.
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Figure 6. NF-κB inhibition triggers RIPK1 kinase activity and mixed lineage kinase like-dependent necroptosis and skin inflammation.
(A, B) Representative macroscopic pictures and skin sections from mice with the indicated age and genotype stained with H&E or immunostained with the indicated antibodies.
Representative images are shown (RelAE-KO c-RelE-KOn = 12 [P7-P10] for H&Eandn ≥ 3 for immunostainings; RelAE-KO c-RelE-KOMlkl−/−n= 3 [P7-P11]&n= 6 [P130-P300] forH&Eandn ≥ 3 for
immunostainings; RelAE-KO c-RelE-KORipk1D138N/D138N n = 11 [P7-P8]&n = 26 [P100-P364] for H&E andn ≥ 3 for immunostainings; RelAE-KO c-RelE-KO TNFR1E-KO n = 3 [P45]&n = 4 [P161-P210] for
H&Eandn ≥ 3 for immunostainings). Scalebars, 50μm. (C)Microscopicquantificationof epidermal thickness (Epi. th.) and inflamedskinarea (Infl. area) on the skin sections from7- to 11-
d-oldmicewith the indicatedgenotypes. Eachdot represents individualmice. *P≤ 0.05; **P≤ 0.01; ***P≤ 0.005. (D)Primarykeratinocytes fromControl (n= 6)orRelAE-KO c-RelE-KO (n= 5)pups
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RIPK1 kinase–dependent, necroptosis-mediated skin inflammation in
RelAE-KO c-RelE-KO was triggered by TNFR1, we generated RelAE-KO c-RelE-
KO mice lacking TNFR1 in keratinocytes. These triple deficient, RelAE-KO
c-RelE-KO TNFR1E-KO, mice did not develop any signs of skin inflam-
mation at least until the age of 6–7 mo, showing that TNFR1 expression
in keratinocytes is essential for the development of inflammatory skin
lesions in RelAE-KO c-RelE-KO mice (Fig 6B and E). Taken together, these
results showed that inhibition of NF-κB triggers skin inflammation by
inducing TNFR1-RIPK1-MLKL–mediated keratinocyte necroptosis.
Discussion
Numerousexperimental andclinical studieshave identifiedTNFasapotent
cytokine that plays a crucial role in the pathogenesis of inflammatory
diseases in human patients and in animal models (Chaudhari et al, 2001;
Apostolaki et al, 2010; Peyrin-Biroulet, 2010;Wullaert et al, 2011; Monaco et al,
2015; Kumari & Pasparakis, 2017). However, the cellular and molecular
mechanisms bywhich TNF causes chronic inflammatory conditions remain
poorly understood. TNF binding to TNFR1 drives the expression of
pro-inflammatory cytokines and chemokines primarily by activating NF-κB-
dependent gene transcription. It was therefore counterintuitive that inhi-
bition of IKK/NF-κB signaling in epidermal keratinocytes caused the
spontaneous development of severe chronic skin inflammation in mice
(Pasparakisetal, 2002;Kumarietal, 2013;Grinberg-Bleyeretal, 2015).Herewe
provide experimental evidence deciphering this paradox, by showing that
IKK/NF-κB inhibition caused skin inflammation by triggering the TNF-
mediated death of keratinocytes. Our genetic studies identified RIPK3-
MLKL-dependent keratinocyte necroptosis as a key inducer of skin in-
flammation in IKK2E-KO and RelAE-KO c-RelE-KO mice, consistent with the
notion that necroptosis is an inflammatory type of cell death. In most
experimental systems, inhibitionof caspase-8activity is required tosensitize
cells tonecroptosis (Pasparakis&Vandenabeele, 2015; Grootjans et al, 2017).
It is therefore notable that keratinocytes lacking IKK2 or RelA and c-Rel
underwent TNF-induced necroptosis in vivo even though they had intact
FADD-caspase-8 signaling. Although it remains unclear how inhibition of
IKK/NF-κB signaling sensitizes keratinocytes to necroptosis in the presence
of intact caspase-8 activity, these results suggest that regulation of nec-
roptosis within the tissue microenvironment may be different from the in
vitro cell culture systems typically used for the study of necroptosis. This is
further supportedby studies showing that inhibition of necroptosis partially
protects mice from systemic inflammatory response syndrome induced by
injection of high dose recombinant TNF in the absence of caspase-8 in-
hibition (Duprez et al, 2011; Newton et al, 2016). Although blocking nec-
roptosis by genetic ablation of MLKL or RIPK3 could strongly inhibit skin
inflammation in IKK2E-KO and RelAE-KO c-RelE-KOmice, thesemice developed
mild skin inflammation later in life indicating that another, necroptosis-
independent,mechanismalsocontributes.Ourfindings that IKK2E-KO FADDE-
KO Ripk3−/− mice were fully protected from skin lesion development pro-
vided experimental proof that FADD-caspase-8–dependent cell death is
responsible for themild skin inflammation observed in IKK2E-KO mice upon
inhibition of necroptosis. Collectively, these findings unequivocally
demonstrated that inhibition of IKK/NF-κB signaling in the epidermis
causes skin inflammation by triggering keratinocyte death primarily by
necroptosis, although FADD-caspase-8–mediated cell death could also
contribute to skin inflammation in the absence of necroptosis.
Our genetic studies demonstrated that inhibition of RIPK1 kinase
activity prevented keratinocyte death and skin inflammation in IKK2E-KO
mice. This finding is consistent with the key role of IKK2 in preventing
TNFR1-induced cell death by enforcing checkpoint 1 by directly phos-
phorylating RIPK1 preventing its activation and the induction of down-
stream cell death signaling (Dondelinger et al, 2015, 2019). Inhibition of
RIPK1 kinase activity was also shown to prevent TNFR1-mediated skin
inflammation in mice with Sharpin deficiency (Sharpincpdm/cpdm) (Berger
et al, 2014; Kumari et al, 2014; Laurienet al, 2020;Webster et al, 2020), which
also disables checkpoint 1 by compromising linear ubiquitination of
complex 1 signaling components. However, in contrast to the IKK2E-KO
mice where skin inflammation was caused primarily by keratinocyte
necroptosis, skin inflammation in Sharpincpdm/cpdm mice was driven
primarily by FADD-caspase-8–dependent keratinocytes apoptosis
(Kumari et al, 2014; Rickard et al, 2014). Therefore, RIPK1 activation could
cause skin inflammation by inducing different cell death signaling
cascades downstream of TNFR1 in the two models, primarily RIPK3-
MLKL–induced necroptosis in IKK2E-KO and mainly FADD-caspase-
8–induced apoptosis in Sharpincpdm/cpdm mice. Although the
mechanisms determining the type of cell death induced by RIPK1 in
response to IKK2 or Sharpin deficiency remain elusive at present,
these findings provide in vivo experimental evidence that RIPK1-
mediated cell death is a potent driver of skin inflammation.
Based on the currently acceptedmodel of the two distinct checkpoints
regulating TNFR1-induced cell death (Justus & Ting, 2015; Ting & Bertrand,
2016), we expected that keratinocyte death caused by combined ablation
of RelA and c-Rel, which inhibits NF-κB–mediated gene transcription
therefore disabling checkpoint 2, would not depend on RIPK1. In contrast
to this prediction, our genetic studies demonstrated that inhibition of
RIPK1 kinase activity prevented keratinocyte death and skin inflammation
in RelAE-KO c-RelE-KO mice. Consistent with these results, we and others
showed previously that inhibition of RIPK1 kinase activity rescued the
embryonic lethality of Rela−/− mice (Vlantis et al, 2016; Xu et al, 2018),
providing evidence that NF-κB subunit deficiency caused RIPK1-mediated
cell death not only in keratinocytes but also in the embryonic liver. To-
gether, these results demonstrate that inhibition of NF-κB–dependent
gene transcription caused RIPK1-mediated cell death in tissues of living
mice and challenge the in vivo relevance of the two-checkpoint model of
TNFR1-mediated cell death regulation, which is primarily based on in vitro
studies in cultured cells. These results also imply that the transcriptional
induction of NF-κB–dependent genes is critical to prevent RIPK1-
dependent cell death. NF-κB regulates the expression of a large num-
ber of pro-survival factors, such as cIAP1/2, XIAP, BclxL, A20, and cFLIP
(Oeckinghaus & Ghosh, 2009), which could be involved in preventing
RIPK1-mediated cell death in keratinocytes. Further studies in relevant in
vivo models will be required to dissect the role of these pro-survival
factors and identify the key NF-κB–dependent mechanisms that are
essential to prevent RIPK1 activation and the maintenance of health skin
were treated with TNF (20 ng/ml) for 18 h. Cell viability was determined by WST-1 assay. Graphs show mean ± SEM from pooled data from four independent experiments.
(E) Representativemacroscopic pictures of mice with the indicated age and genotype. Multiple comparisons of groups were evaluated by Kruskal–Wallis one-way ANOVAs with post-Dunn
corrections. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.005.
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homeostasis. Whereas inhibition of RIPK1 kinase activity strongly pre-
vented skin lesiondevelopment inboth the IKK2E-KO andRelAE-KO c-RelE-KO
mice, someof thesemice did develop verymild skin inflammation later in
life suggesting that RIPK1-independent cell death also contributes, albeit
to a much lesser extent. Taken together, our in vivo studies provided
experimental evidence that TNFR1drives severe skin inflammation inmice
with keratinocyte-specific IKK/NF-κB inhibition by inducing RIPK1-
mediated necroptosis and apoptosis, suggesting that RIPK1-dependent
cell death could also contribute to human inflammatory skin diseases.
Materials and Methods
Ikk2fl/fl (Pasparakis et al, 2002), Faddfl/fl (Mc Guire et al, 2010), K14-
Cre (Hafner et al, 2004),Mlkl−/− (Dannappel et al, 2014), Ripk1D138N/D138N
(Polykratis et al, 2014), Relafl/fl (Luedde et al, 2008), c-Relfl/fl (Heise et al,
2014), Tnfr1fl/fl (Van Hauwermeiren et al, 2013), Ripk3−/− (Newton et al,
2004), andRipk3fl/fl (Newtonet al, 2016)weredescribedpreviously.Mice
were kept at the specific pathogen-free animal facilities of the Institute for
Genetics and theCECADResearchCenter, University of Cologneunder a 12h
light cycle, and given a regular chow diet. GF IKK2E-KO mice were generated
andkeptat thegnotobiotic facilityof the Institute for Laboratory Animal
Science and Central Animal facility (Hannover Medical School).
Animals received appropriate care and were euthanized when
they reached pre-determined criteria based on the development
of macroscopically visible skin lesions to minimize suffering. Mice
were assigned at random to groups within specific genotypes.
Mouse studies were performed in a blinded fashion. All animal
procedures were conducted in accordance with European, na-
tional and institutional guidelines and protocols and were ap-
proved by local governmental authorities (Landesamt für Natur,
Umwelt und Verbraucherschutz Nordrhein-Westfalen, and the Lower
Saxony State Office for Consumer Protection and Food Safety
[LAVES]).
Histological analysis and immunostainings of tissue sections
Skin from mice was embedded in paraffin or snap frozen in OCT
compound. Antigen retrieval for paraffin sections was performed in
citrate buffer, pH6. Keratin 14 (MS-115; Neomarkers), Keratin 6 (PRB-
169P; Covance), Keratin 10 (PRB-159P; Covance), TUNEL (Promega)/
Active caspase-3 (9661; Cell Signalling) staining was performed on
paraffin, and F4/80 (clone A3-1, homemade or MCA497G; Bio-Rad)
staining on cryo sections. The staining was visualized with Alexa-
488 or Alexa-567 conjugated secondary antibody. Measurement of
epidermal thickness and inflamed area was done as described
before (Jiao et al, 2020). Briefly, five optical fields per section were
measured to quantify epidermal thickness. In each field, four
measurements were performed. Percentage of inflamed area was
determined as the percentage of inflamed versus total number of
optical fields at 20× on individual skin section. Quantification of
TUNEL and CC3 staining was performed on five optical fields per
sections at 20× magnification. All images were acquired using either
a Zeiss Meta 710 confocal, Leica SCN400 slide scanner or Leica
DM5500 B microscope, and processed with ImageJ, Leica digital
image hub or Leica Aperio ImageScope software.
Keratinocytes isolation, culture, and cell death assessment
Keratinocytes from newborn pups were isolated as described using
dispase II (D4693; Sigma-Aldrich). Briefly, the skin from newborn
mice was incubated overnight at 4°C in dispase II. After incubation,
epidermis was separated and placed in TrypLE (12605-010; Gibco)
for 20 min followed by making single cell suspension using low Ca2+
DMEM/Ham’s F12 medium (F 9092-0.46; Biochrom) with 10% chelax-
treated FCS and supplements. Cells were grown in the Ca2+ DMEM/
Ham’s F12 medium. For cell death assay, 20–25,000 keratinocytes
were seeded in collagen coated 96 well plates, stimulated with
20 ng/ml TNF with or without Z-VAD (20 μM) for 18 h and viability was
assessed with WST-1 assay as per manufacturer’s instruction
(Roche).
RNA isolation, cDNA synthesis, and quantitative RT-PCR
Total RNA from skin tissue was extracted with Trizol Reagent (Life
Technologies) and purified on RNeasy Columns (QIAGEN). cDNA was
prepared using Superscript III cDNA synthesis Kit (Life Technolo-
gies). qRT-PCR of Il1-b, Il-6, Il-24, Ccl3, and Ccl4 genes was performed
with Sybr green. Hprt was used as reference genes. Primer se-
quences were used as described before (Kumari et al, 2013). qRT-
PCR of Cflar, Birc2, Birc3, and Birc5 was performed with Taqman
using QIAGEN primers. Data were analyzed according to the ΔCT
method.
Separation of epidermis
Mouse epidermis was separated after incubating skin samples in
0.5 M ammonium thiocyanate (NH4SCN) in phosphate buffer, pH 6.8
(0.1 M NH2HPO4 and 0.1 M KH2PO4) for 30 min on ice.
Statistical analysis
Data shown in column graphs represent mean ± SEM. For statistical
analysis of data from qRT-PCR, quantification of epidermal thick-
ness and inflamed area, when data did not fulfill the criteria for
Gaussian distribution, nonparametric Mann–Whitney test was
performed. For the keratinocyte’s death experiments, multiple
comparisons of groups were evaluated by ordinary or Kruskal–
Wallis one-way ANOVAs with post-Dunn corrections. *P ≤ 0.05; **P ≤
0.01; ***P ≤ 0.005. Statistical analysis was performed using
GraphPad Prism.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
202000956.
Acknowledgements
We thank E Gareus, J Kuth, B Kühnel, E Stade, and C Uthoff-Hachenberg for
excellent technical assistance. We thank V Dixit and K Newton, Genentech
Inc, for Ripk3−/− and Ripk3fl/fl mice, and G Kollias for Tnfr1fl/fl mice. Research
NF-kB prevents keratinocyte necroptosis and skin inflammation Kumari et al. https://doi.org/10.26508/lsa.202000956 vol 4 | no 6 | e202000956 12 of 14
reported in this publication was supported by funding from the Deutsche
Forschungsgemeinschaft (DFG, German Research Foundation); projects
SFB829 (project no. 73111208), SFB1403 (project no. 414786233), and under
Germany’s Excellence Strategy–EXC 2030 CECAD (project no. 390661388) to M
Pasparakis, SPP1656 (project number 220134278) to M Pasparakis and A
Bleich and BL953/5-2 to A Bleich.
Author Contributions
S Kumari: conceptualization, data curation, formal analysis, su-
pervision, validation, investigation, visualization, methodology, and
writing—original draft, review, and editing.
T-M Van: formal analysis, validation, investigation, and methodology.
D Preukschat: formal analysis, validation, investigation, and
methodology.
H Schuenke: formal analysis, validation, investigation, andmethodology.
M Basic: investigation and methodology.
A Bleich: resources, investigation, and methodology.
U Klein: resources.
M Pasparakis: conceptualization, resources, formal analysis, su-
pervision, funding acquisition, investigation, project administra-
tion, and writing—original draft, review, and editing.
Conflict of Interest Statement
The authors declare that they have no conflict of interest.
References
Apostolaki M, Armaka M, Victoratos P, Kollias G (2010) Cellular mechanisms of
TNF function in models of inflammation and autoimmunity. Curr Dir
Autoimmun 11: 1–26. doi:10.1159/000289195
BarkettM, Gilmore TD (1999) Control of apoptosis by Rel/NF-kappaB transcription
factors. Oncogene 18: 6910–6924. doi:10.1038/sj.onc.1203238
Beg AA, Baltimore D (1996) An essential role for NF-kappaB in preventing
TNF-alpha-induced cell death. Science 274: 782–784. doi:10.1126/
science.274.5288.782
Berger SB, Kasparcova V, Hoffman S, Swift B, Dare L, Schaeffer M, Capriotti C,
Cook M, Finger J, Hughes-Earle A, et al (2014) Cutting edge: RIP1 kinase
activity is dispensable for normal development but is a key regulator
of inflammation in SHARPIN-deficient mice. J Immunol 192: 5476–5480.
doi:10.4049/jimmunol.1400499
Bonnet MC, Preukschat D, Welz PS, van Loo G, Ermolaeva MA, BlochW, Haase I,
Pasparakis M (2011) The adaptor protein FADD protects epidermal
keratinocytes from necroptosis in vivo and prevents skin
inflammation. Immunity 35: 572–582. doi:10.1016/j.immuni.2011.08.014
Cai Z, JitkaewS, Zhao J, ChiangHC, Choksi S, Liu J,WardY,WuLG, Liu ZG (2014) Plasma
membrane translocation of trimerized MLKL protein is required for TNF-
induced necroptosis. Nat Cell Biol 16: 55–65. doi:10.1038/ncb2883
ChaudhariU, RomanoP,Mulcahy LD, Dooley LT, BakerDG, GottliebAB (2001) Efficacy
and safety of infliximab monotherapy for plaque-type psoriasis: A
randomised trial. Lancet 357: 1842–1847. doi:10.1016/s0140-6736(00)04954-0
Chen C, Edelstein LC, Gelinas C (2000) The Rel/NF-kappaB family directly
activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol
20: 2687–2695. doi:10.1128/mcb.20.8.2687-2695.2000
Chen X, Li W, Ren J, Huang D, He WT, Song Y, Yang C, Li W, Zheng X, Chen P, et al
(2014) Translocation of mixed lineage kinase domain-like protein to
plasma membrane leads to necrotic cell death. Cell Res 24: 105–121.
doi:10.1038/cr.2013.171
ChristoffersonDE, Li Y, Yuan J (2014) Control of life-or-death decisions by RIP1 kinase.
Annu Rev Physiol 76: 129–150. doi:10.1146/annurev-physiol-021113-170259
Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, Wachsmuth L, Eftychi C,
Lin J, Corona T, Hermance N, et al (2014) RIPK1 maintains epithelial
homeostasis by inhibiting apoptosis and necroptosis. Nature 513:
90–94. doi:10.1038/nature13608
Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I,
Hulpiau P,Weber K, Sehon CA,Marquis RW, et al (2014)MLKL compromises
plasma membrane integrity by binding to phosphatidylinositol
phosphates. Cell Rep 7: 971–981. doi:10.1016/j.celrep.2014.04.026
Dondelinger Y, Delanghe T, Priem D, Wynosky-Dolfi MA, Sorobetea D, Rojas-
Rivera D, Giansanti P, Roelandt R, Gropengiesser J, Ruckdeschel K, et al
(2019) Serine 25 phosphorylation inhibits RIPK1 kinase-dependent
cell death in models of infection and inflammation. Nat Commun 10:
1729. doi:10.1038/s41467-019-09690-0
Dondelinger Y, Jouan-Lanhouet S, Divert T, Theatre E, Bertin J, Gough PJ,
Giansanti P, Heck AJ, Dejardin E, Vandenabeele P, et al (2015) NF-
kappaB-Independent role of IKKalpha/IKKbeta in preventing RIPK1
kinase-dependent apoptotic and necroptotic cell death during TNF
signaling. Mol Cell 60: 63–76. doi:10.1016/j.molcel.2015.07.032
Duprez L, Takahashi N, Van Hauwermeiren F, Vandendriessche B, Goossens V,
VandenBergheT,DeclercqW, Libert C, CauwelsA, VandenabeeleP (2011) RIP
kinase-dependent necrosis drives lethal systemic inflammatory response
syndrome. Immunity 35: 908–918. doi:10.1016/j.immuni.2011.09.020
Grinberg-Bleyer Y, Dainichi T, Oh H, Heise N, Klein U, Schmid RM, Hayden MS,
Ghosh S (2015) Cutting edge: NF-kappaB p65 and c-Rel control
epidermal development and immune homeostasis in the skin. J
Immunol 194: 2472–2476. doi:10.4049/jimmunol.1402608
Grootjans S, Vanden Berghe T, Vandenabeele P (2017) Initiation and
execution mechanisms of necroptosis: An overview. Cell Death Differ
24: 1184–1195. doi:10.1038/cdd.2017.65
Hafner M, Wenk J, Nenci A, Pasparakis M, Scharffetter-Kochanek K, Smyth N,
Peters T, Kess D, Holtkotter O, Shephard P, et al (2004) Keratin 14 Cre
transgenic mice authenticate keratin 14 as an oocyte-expressed
protein. Genesis 38: 176–181. doi:10.1002/gene.20016
Heise N, De Silva NS, Silva K, Carette A, Simonetti G, Pasparakis M, Klein U
(2014) Germinal center B cell maintenance and differentiation are
controlled by distinct NF-kappaB transcription factor subunits. J Exp
Med 211: 2103–2118. doi:10.1084/jem.20132613
Jiao H, Wachsmuth L, Kumari S, Schwarzer R, Lin J, Eren RO, Fisher A, Lane R,
Young GR, Kassiotis G, et al (2020) Z-nucleic-acid sensing triggers
ZBP1-dependent necroptosis and inflammation. Nature 580: 391–395.
doi:10.1038/s41586-020-2129-8
Justus SJ, Ting AT (2015) Cloaked in ubiquitin, a killer hides in plain sight: The
molecular regulation of RIPK1. Immunol Rev 266: 145–160. doi:10.1111/
imr.12304
Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat
Immunol 3: 221–227. doi:10.1038/ni0302-221
Kumari S, Bonnet MC, Ulvmar MH, Wolk K, Karagianni N, Witte E, Uthoff-
Hachenberg C, Renauld JC, Kollias G, Toftgard R, et al (2013) Tumor
necrosis factor receptor signaling in keratinocytes triggers
interleukin-24-dependent psoriasis-like skin inflammation in mice.
Immunity 39: 899–911. doi:10.1016/j.immuni.2013.10.009
Kumari S, Pasparakis M (2017) Epithelial cell death and inflammation in skin.
Curr Top Microbiol Immunol 403: 77–93. doi:10.1007/82_2015_466
Kumari S, Redouane Y, Lopez-Mosqueda J, Shiraishi R, Romanowska M,
Lutzmayer S, Kuiper J, Martinez C, Dikic I, Pasparakis M, et al (2014)
Sharpin prevents skin inflammation by inhibiting TNFR1-induced
keratinocyte apoptosis. Elife 3: e03422. doi:10.7554/elife.03422
Lafont E, Draber P, Rieser E, Reichert M, Kupka S, de Miguel D, Draberova H,
von Massenhausen A, Bhamra A, Henderson S, et al (2018) TBK1 and
IKKepsilon prevent TNF-induced cell death by RIPK1 phosphorylation.
Nat Cell Biol 20: 1389–1399. doi:10.1038/s41556-018-0229-6
NF-kB prevents keratinocyte necroptosis and skin inflammation Kumari et al. https://doi.org/10.26508/lsa.202000956 vol 4 | no 6 | e202000956 13 of 14
Laurien L, Nagata M, Schunke H, Delanghe T, Wiederstein JL, Kumari S,
Schwarzer R, Corona T, Kruger M, Bertrand MJM, et al (2020)
Autophosphorylation at serine 166 regulates RIP kinase 1-mediated
cell death and inflammation. Nat Commun 11: 1747. doi:10.1038/
s41467-020-15466-8
Luedde T, Heinrichsdorff J, de Lorenzi R, De Vos R, Roskams T, Pasparakis M
(2008) IKK1 and IKK2 cooperate to maintain bile duct integrity in the
liver. Proc Natl Acad Sci U S A 105: 9733–9738. doi:10.1073/
pnas.0800198105
Mc Guire C, Volckaert T, Wolke U, Sze M, de Rycke R, Waisman A, Prinz M,
Beyaert R, Pasparakis M, van Loo G (2010) Oligodendrocyte-specific
FADD deletion protects mice from autoimmune-mediated
demyelination. J Immunol 185: 7646–7653. doi:10.4049/
jimmunol.1000930
Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis
via two sequential signaling complexes. Cell 114: 181–190. doi:10.1016/
s0092-8674(03)00521-x
Monaco C, Nanchahal J, Taylor P, Feldmann M (2015) Anti-TNF therapy: Past,
present and future. Int Immunol 27: 55–62. doi:10.1093/intimm/dxu102
Moriwaki K, Balaji S, Bertin J, Gough PJ, Chan FK (2017) Distinct kinase-
independent role of RIPK3 in CD11c(+) mononuclear phagocytes in
cytokine-induced tissue repair. Cell Rep 18: 2441–2451. doi:10.1016/
j.celrep.2017.02.015
Moriwaki K, Balaji S, McQuade T, Malhotra N, Kang J, Chan FK (2014) The
necroptosis adaptor RIPK3 promotes injury-induced cytokine
expression and tissue repair. Immunity 41: 567–578. doi:10.1016/
j.immuni.2014.09.016
Moriwaki K, Chan FK (2017) The inflammatory signal adaptor RIPK3: Functions
beyond necroptosis. Int Rev Cell Mol Biol 328: 253–275. doi:10.1016/
bs.ircmb.2016.08.007
Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S,
Lewis R, Lalaoui N, Metcalf D, Webb AI, et al (2013) The pseudokinase
MLKL mediates necroptosis via a molecular switch mechanism.
Immunity 39: 443–453. doi:10.1016/j.immuni.2013.06.018
Newton K, Dugger DL, Maltzman A, Greve JM, Hedehus M, Martin-McNulty B,
Carano RA, Cao TC, van Bruggen N, Bernstein L, et al (2016) RIPK3
deficiency or catalytically inactive RIPK1 provides greater benefit than
MLKL deficiency in mouse models of inflammation and tissue injury.
Cell Death Differ 23: 1565–1576. doi:10.1038/cdd.2016.46
Newton K, Sun X, Dixit VM (2004) Kinase RIP3 is dispensable for normal NF-
kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis
factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol 24:
1464–1469. doi:10.1128/mcb.24.4.1464-1469.2004
Oeckinghaus A, Ghosh S (2009) The NF-kappaB family of transcription factors
and its regulation. Cold Spring Harb Perspect Biol 1: a000034.
doi:10.1101/cshperspect.a000034
Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A,
Krampert M, Goebeler M, Gillitzer R, Israel A, et al (2002) TNF-mediated
inflammatory skin disease in mice with epidermis-specific deletion of
IKK2. Nature 417: 861–866. doi:10.1038/nature00820
Pasparakis M, Haase I, Nestle FO (2014) Mechanisms regulating skin immunity
and inflammation. Nat Rev Immunol 14: 289–301. doi:10.1038/nri3646
Pasparakis M, Vandenabeele P (2015) Necroptosis and its role in
inflammation. Nature 517: 311–320. doi:10.1038/nature14191
Peyrin-Biroulet L (2010) Anti-TNF therapy in inflammatory bowel diseases: A
huge review. Minerva Gastroenterol Dietol 56: 233–243.
Polykratis A, Hermance N, Zelic M, Roderick J, Kim C, Van TM, Lee TH, Chan FKM,
Pasparakis M, Kelliher MA (2014) Cutting edge: RIPK1 kinase inactive
mice are viable and protected from TNF-induced necroptosis in vivo. J
Immunol 193: 1539–1543. doi:10.4049/jimmunol.1400590
Rickard JA, Anderton H, Etemadi N, Nachbur U, Darding M, Peltzer N, Lalaoui N,
Lawlor KE, Vanyai H, Hall C, et al (2014) TNFR1-dependent cell death
drives inflammation in Sharpin-deficient mice. Elife 3: e03464.
doi:10.7554/elife.03464
Stehlik C, deMartin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J (1998) Nuclear
factor (NF)-kappaB-regulated X-chromosome-linked iap gene
expression protects endothelial cells from tumor necrosis factor alpha-
induced apoptosis. J Exp Med 188: 211–216. doi:10.1084/jem.188.1.211
Stratis A, Pasparakis M, Markur D, Knaup R, Pofahl R, Metzger D, Chambon P,
Krieg T, Haase I (2006a) Localized inflammatory skin disease following
inducible ablation of I kappa B kinase 2 in murine epidermis. J Invest
Dermatol 126: 614–620. doi:10.1038/sj.jid.5700092
Stratis A, Pasparakis M, Rupec RA, Markur D, Hartmann K, Scharffetter-
Kochanek K, Peters T, van Rooijen N, Krieg T, Haase I (2006b)
Pathogenic role for skin macrophages in a mouse model of
keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest
116: 2094–2104. doi:10.1172/jci27179
Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X, et al
(2012) Mixed lineage kinase domain-like protein mediates necrosis
signaling downstream of RIP3 kinase. Cell 148: 213–227. doi:10.1016/
j.cell.2011.11.031
Ting AT, Bertrand MJM (2016) More to life than NF-kappaB in TNFR1 signaling.
Trends Immunol 37: 535–545. doi:10.1016/j.it.2016.06.002
Van Hauwermeiren F, Armaka M, Karagianni N, Kranidioti K, Vandenbroucke
RE, Loges S, Van Roy M, Staelens J, Puimege L, Palagani A, et al (2013)
Safe TNF-based antitumor therapy following p55TNFR reduction in
intestinal epithelium. J Clin Invest 123: 2590–2603. doi:10.1172/jci65624
Varfolomeev E, Vucic D (2018) Intracellular regulation of TNF activity in health
and disease. Cytokine 101: 26–32. doi:10.1016/j.cyto.2016.08.035
Vlantis K, Wullaert A, Polykratis A, Kondylis V, Dannappel M, Schwarzer R, Welz
P, Corona T, Walczak H, Weih F, et al (2016) NEMO prevents RIP kinase
1-mediated epithelial cell death and chronic intestinal inflammation
by NF-kappaB-dependent and -independent functions. Immunity 44:
553–567. doi:10.1016/j.immuni.2016.02.020
Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr. (1998) NF-
kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and
c-IAP2 to suppress caspase-8 activation. Science 281: 1680–1683.
doi:10.1126/science.281.5383.1680
Wang L, Du F, Wang X (2008) TNF-alpha induces two distinct caspase-8
activation pathways. Cell 133: 693–703. doi:10.1016/j.cell.2008.03.036
Webster JD, Kwon YC, Park S, Zhang H, Corr N, Ljumanovic N, Adedeji AO,
Varfolomeev E, Goncharov T, Preston J, et al (2020) RIP1 kinase activity
is critical for skin inflammation but not for viral propagation. J Leukoc
Biol 107: 941–952. doi:10.1002/jlb.3ma1219-398r
Wertz IE, Newton K, Seshasayee D, Kusam S, Lam C, Zhang J, Popovych N,
Helgason E, Schoeffler A, Jeet S, et al (2015) Phosphorylation and
linear ubiquitin direct A20 inhibition of inflammation. Nature 528:
370–375. doi:10.1038/nature16165
Wullaert A, Bonnet MC, Pasparakis M (2011) NF-kappaB in the regulation of
epithelial homeostasis and inflammation. Cell Res 21: 146–158.
doi:10.1038/cr.2010.175
Xu C, Wu X, Zhang X, Xie Q, Fan C, Zhang H (2018) Embryonic lethality and host
immunity of RelA-deficient mice are mediated by both apoptosis and
necroptosis. J Immunol 200: 271–285. doi:10.4049/jimmunol.1700859
Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J, Liu ZG (2012) Mixed lineage kinase
domain-like is a key receptor interacting protein 3 downstream
component of TNF-induced necrosis. Proc Natl Acad Sci U S A 109:
5322–5327. doi:10.1073/pnas.1200012109
License: This article is available under a Creative
Commons License (Attribution 4.0 International, as
described at https://creativecommons.org/
licenses/by/4.0/).
NF-kB prevents keratinocyte necroptosis and skin inflammation Kumari et al. https://doi.org/10.26508/lsa.202000956 vol 4 | no 6 | e202000956 14 of 14
